NSRX · Nasus Pharma Ltd · Shareholders & Ownership
Every disclosed holder of NSRX in one list: 13F institutions, Schedule 13D and 13G filers, insiders (Forms 3, 4 and 5) and registered funds, each from its own latest filing. Holders nest by CIK and SEC reporting links, never by name, and each is summed once.
Who Owns NSRX
13F quarter Jun 30, 2026No chart: shares outstanding cannot be set against these holders.
| Holder group | Shares | % Out |
|---|---|---|
| Institutional (13F) | 2,150,411 | — |
| Insiders (Forms 3, 4, 5) | 0 | — |
| 13D/G-only blocks | 6,361,738 | — |
| Registered funds (N-PORT, not summed) | 0 | — |
% Out is unavailable: a foreign private issuer reports ordinary shares, a different unit from the listed shares.
Insiders are listed but not summed: the issuer has more than one class of common stock and Forms 3, 4 and 5 report one issuer-wide balance across them.
13D/G-only counts each filer's latest 13D or 13G that no 13F report of the listing contains, that names no 13F filer and that no counted insider files. Funds are never summed: their shares sit inside their advisers' 13F reports.
Holders of NSRX
| # | Holder | Shares | As of | Notes |
|---|---|---|---|---|
| 1 |
|
1,924,476 | ||
| 1.1 |
|
1,901,311 | ||
| 2 |
Megiddo Dalia
Insider
CIK 1599618 · Mar 18, 2026
Director, Chief Development Officer, issuer-wide, not summed
|
1,894,068 | ||
| 2.1 |
|
1,888,873 | ||
| 3 |
|
1,338,463 | ||
| 3.1 |
|
1,383,512 | ||
| 4 |
Balyasny Asset Management L.P.
13F
CIK 1218710 · Registered investment adviser · Jun 30, 2026
|
898,473 | ||
| 4.1 |
Balyasny Asset Management L.P.
13G
CIK 1218710 · Registered investment adviser · Jun 30, 2026
Rule 13d-1(b), qualified institution, not summed
|
1,169,909 | ||
| 5 |
Cable Car Capital, LP
13F
CIK 1699575 · Registered investment adviser · Jun 30, 2026
|
616,081 | ||
| 6 |
|
612,913 | ||
| 7 |
|
575,129 | ||
| 8 |
Velan Capital Investment Management LP
13F
CIK 1848809 · Registered investment adviser · Jun 30, 2026
|
359,390 | ||
| 9 |
Teleman Dan Benjamin
Insider
CIK 2122500 · Jun 17, 2026
Director, Chief Executive Officer, issuer-wide, not summed
|
163,541 | ||
| 10 |
Hudson Bay Capital Management LP
13F
CIK 1393825 · Registered investment adviser · Jun 30, 2026
|
134,771 | ||
| 11 |
Bleichroeder LP
13F
CIK 1781002 · Registered investment adviser · Jun 30, 2026
|
89,848 | ||
| 12 |
CITADEL ADVISORS LLC
13F
CIK 1423053 · Registered investment adviser · Jun 30, 2026
|
22,004 | ||
| 13 |
XTX Topco Ltd
13F
CIK 1828301 · Unknown · Jun 30, 2026
|
16,640 | ||
| 14 |
RENAISSANCE TECHNOLOGIES LLC
13F
CIK 1037389 · Registered investment adviser · Jun 30, 2026
|
12,200 | ||
| 15 |
MORGAN STANLEY
13F
CIK 895421 · Holding company · Jun 30, 2026
|
1,000 | ||
| 16 |
Caitong International Asset Management Co., Ltd
13F
CIK 1963355 · Unknown · Jun 30, 2026
|
4 |
Shares are restated onto today's split basis. Change compares each row with the same holder's previous filing in the same source; a dash means there is none to compare. Nested 13D/G, insider and fund rows are not summed, since a 13F report already holds them.